💨 Abstract

Ocugen, Inc. reported a second-quarter loss of $14.7 million, equivalent to 5 cents per share. The Malvern, Pennsylvania-based biotech company, which specializes in knee implants, generated $1.4 million in revenue for the period.

Courtesy: WTOP Staff